CA3248925A1 - SYNTHESIS OF A KIF18A INHIBITOR - Google Patents
SYNTHESIS OF A KIF18A INHIBITORInfo
- Publication number
- CA3248925A1 CA3248925A1 CA3248925A CA3248925A CA3248925A1 CA 3248925 A1 CA3248925 A1 CA 3248925A1 CA 3248925 A CA3248925 A CA 3248925A CA 3248925 A CA3248925 A CA 3248925A CA 3248925 A1 CA3248925 A1 CA 3248925A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- solvent
- base
- benzyl
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C313/02—Sulfinic acids; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263303470P | 2022-01-26 | 2022-01-26 | |
| US63/303,470 | 2022-01-26 | ||
| PCT/US2023/011636 WO2023146973A1 (en) | 2022-01-26 | 2023-01-26 | Synthesis of a kif18a inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3248925A1 true CA3248925A1 (en) | 2023-08-03 |
Family
ID=85328813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3248925A Pending CA3248925A1 (en) | 2022-01-26 | 2023-01-26 | SYNTHESIS OF A KIF18A INHIBITOR |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250129050A1 (enExample) |
| EP (1) | EP4469437A1 (enExample) |
| JP (1) | JP2025505892A (enExample) |
| KR (1) | KR20240144140A (enExample) |
| CN (1) | CN118922406A (enExample) |
| AR (1) | AR128353A1 (enExample) |
| AU (1) | AU2023211589A1 (enExample) |
| CA (1) | CA3248925A1 (enExample) |
| IL (1) | IL314221A (enExample) |
| MX (1) | MX2024009163A (enExample) |
| TW (1) | TW202342451A (enExample) |
| WO (1) | WO2023146973A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20211475A1 (es) | 2018-12-20 | 2021-08-05 | Amgen Inc | Inhibidores de kif18a |
| WO2024039829A1 (en) | 2022-08-18 | 2024-02-22 | Accent Therapeutics, Inc. | Inhibitors of kif18a and uses thereof |
| CN115925589A (zh) * | 2022-12-26 | 2023-04-07 | 诚达药业股份有限公司 | 一种脂肪族亚磺酸钙盐及其制备方法 |
| WO2025036479A1 (zh) * | 2023-08-16 | 2025-02-20 | 上海湃隆生物科技有限公司 | 驱动蛋白kif18a抑制剂及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20211475A1 (es) * | 2018-12-20 | 2021-08-05 | Amgen Inc | Inhibidores de kif18a |
| TW202203919A (zh) * | 2020-04-14 | 2022-02-01 | 美商安進公司 | 用於治療贅生性疾病之ｋｉｆ１８ａ抑制劑 |
-
2023
- 2023-01-26 CA CA3248925A patent/CA3248925A1/en active Pending
- 2023-01-26 IL IL314221A patent/IL314221A/en unknown
- 2023-01-26 KR KR1020247024721A patent/KR20240144140A/ko active Pending
- 2023-01-26 US US18/832,887 patent/US20250129050A1/en active Pending
- 2023-01-26 AU AU2023211589A patent/AU2023211589A1/en active Pending
- 2023-01-26 CN CN202380018655.9A patent/CN118922406A/zh active Pending
- 2023-01-26 WO PCT/US2023/011636 patent/WO2023146973A1/en not_active Ceased
- 2023-01-26 JP JP2024543870A patent/JP2025505892A/ja active Pending
- 2023-01-26 EP EP23706921.6A patent/EP4469437A1/en active Pending
- 2023-01-26 AR ARP230100178A patent/AR128353A1/es unknown
- 2023-01-26 MX MX2024009163A patent/MX2024009163A/es unknown
- 2023-01-30 TW TW112103047A patent/TW202342451A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2024009163A (es) | 2024-08-09 |
| AR128353A1 (es) | 2024-04-24 |
| CN118922406A (zh) | 2024-11-08 |
| KR20240144140A (ko) | 2024-10-02 |
| AU2023211589A1 (en) | 2024-07-25 |
| WO2023146973A1 (en) | 2023-08-03 |
| EP4469437A1 (en) | 2024-12-04 |
| IL314221A (en) | 2024-09-01 |
| US20250129050A1 (en) | 2025-04-24 |
| JP2025505892A (ja) | 2025-03-03 |
| TW202342451A (zh) | 2023-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250129050A1 (en) | Synthesis of a kif18a inhibitor | |
| CA2935601C (en) | 5-fluoro-4-imino-3-(alkyl/substituted alkyl)-1-(arylsulfonyl)-3,4-dihydropyrimidin-2(1h)-one and processes for their preparation | |
| EP3271018B1 (en) | Processes and intermediates for the preparation of pimavanserin | |
| JP6118965B2 (ja) | ２環性化合物 | |
| JP5934182B2 (ja) | ４−｛４−［（｛［４−クロロ−３−（トリフルオロメチル）フェニル］アミノ｝カルボニル）アミノ］−３−フルオロフェノキシ｝−ｎ−メチルピリジン−２−カルボキサミド、その塩及び一水和物の製造方法 | |
| AU2020267299B2 (en) | Methods of making protein deacetylase inhibitors | |
| CN120607463A (zh) | 用于制备pde4抑制剂的方法 | |
| TW201829378A (zh) | 無溶劑烷類磺化反應 | |
| EP4095132A1 (en) | Isoindoline derivative, and pharmaceutical composition and use thereof | |
| US20230348412A1 (en) | Method for preparing glp-1 receptor agonist | |
| CA2351528C (en) | Process for the preparation of a piperazine derivative | |
| TW201643135A (zh) | 製備３－氯－２－乙烯基苯基磺酸酯之方法 | |
| MXPA04008109A (es) | Metodo para preparar cloruro de bencisoxasol metano sulfonilo y su amidacion para formar zonisamida. | |
| EP4063351A1 (en) | Preparation method of quinoline derivative compounds | |
| KR20140013232A (ko) | Ｎ-(2-히드록시에틸)니코틴아미드 및 니코란딜의 제조방법 | |
| EP3348554B1 (en) | Method for producing triazole compound | |
| RU2466983C2 (ru) | Способ синтеза сульфонилгалогенидов и сульфонамидов из солей сульфоновых кислот | |
| EA052216B1 (ru) | Синтез ингибитора kif18a | |
| EP3109236B1 (en) | Scalable process for the preparation of sorafenib tosylate ethanol solvate and sorafenib tosylate form iii | |
| EP3805244B1 (en) | Synthesis of glycoconjugate derivatives of a bile acid | |
| CN111100111B (zh) | 一种制备苯并噻吩衍生物的方法 | |
| WO2021175959A1 (en) | Process for the preparation of 5-chloro-3-alkylsulfanyl-pyridine-2-carboxylic acid amides and carboxylates | |
| KR20140027921A (ko) | 디(아릴아미노)아릴 화합물의 제조 방법 및 그 합성 중간체 | |
| HK1251233A1 (en) | Method for producing dicarboxylic acid compound | |
| IT202300023508A1 (it) | Processo per la preparazione della forma polimorfa iii di tapinarof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A00 | Application filed |
Free format text: ST27 STATUS EVENT CODE: A-0-1-A10-A00-A101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION RECEIVED - PCT Effective date: 20240716 |
|
| A00 | Application filed |
Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A00-A102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: COMPLIANCE REQUIREMENTS DETERMINED MET Effective date: 20241220 |
|
| A15 | Pct application entered into the national or regional phase |
Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A15-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: NATIONAL ENTRY REQUIREMENTS DETERMINED COMPLIANT Effective date: 20241220 |
|
| P18 | Priority claim added or amended |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P18-P105 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRIORITY CLAIM REQUIREMENTS DETERMINED COMPLIANT Effective date: 20241220 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250110 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD Year of fee payment: 2 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250120 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20250120 Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250120 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250121 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20250121 Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250121 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250303 Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST TO REGISTER A DOCUMENT RECEIVED Effective date: 20250303 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REGISTER A DOCUMENT REQUIREMENTS DETERMINED COMPLIANT Effective date: 20260417 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260420 Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST TO REGISTER A DOCUMENT RECEIVED Effective date: 20260420 Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REGISTER A DOCUMENT REQUIREMENTS DETERMINED COMPLIANT Effective date: 20260420 |